Branchio-Oto-Renal (BOR) syndrome is transmitted as an autosomal dominant disorder, affects an estimated 2% of profoundly deaf children, and is caused by mutations in the human EYA1 gene. However, in up to half of the reported cases, EYA1 mutation screening is negative. This finding has been taken as evidence of genetic heterogeneity. Mutation screening of the coding region of EYA1 in a panel of families linked to chromosome 8 was conducted using SSCP and direct sequencing. Only one point mutation in five probands was detected. However, complex rearrangements, such as inversions or large deletions, were discovered in the other four patients using Southern blot analysis. These data suggest that more complex rearrangements may remain undetected in EYA1 since SSCP and sequencing were commonly used to detect mutations in this gene.
Introduction
Branchio-Oto-Renal (BOR) syndrome (MIM 113650) is an autosomal dominant disorder first described by Melnick et al. 1, 2 and further delineated by Fraser et al. 3 The prevalence is estimated at 1 : 40 000 in the general population, and the syndrome has been reported to occur in about 2% of profoundly deaf children. 4 Clinical expression is highly variable within and among families, but typical manifestations are branchial arch anomalies (preauricular pits, branchial fistulae and pinnae abnormalities), hearing loss (conductive, sensorineural or mixed) and renal hypoplasia. 5, 6 BOR syndrome was localised to chromosome 8q13.3 by linkage analysis 7 -14 and deletion mapping. 11, 14, 15 Recently, a second locus was identified at chromosome 1q31. 16 Mutations in EYA1 at 8q13.3, the human homologue of the Drosophila eyes absent gene, have been shown to underlie BOR syndrome 17 -22 and Branchio-Oto (BO) syndrome in some families. 22, 23 The EYA1 gene is composed of seventeen exons spanning 156 kb and encodes a 559 amino acid protein. Exons 9 to 16 encode a highly conserved 271 amino acid domain, the eya homologous region (eyaHR), where most of the BO/BOR mutations have been found. Expression studies of EYA1 in mouse suggest a role in the development of the ear and kidney; consistent with these findings, EYA1 is highly expressed in foetal kidney and brain. 17 In Drosophila, EYA1 is essential for eye formation 24 and in humans, EYA1 mutations have been found in three patients with congenital cataracts. 25 Since EYA1 was identified as the candidate gene for BOR, only about half of patients with the clinical diagnosis of either BO or BOR syndrome have been reported to carry mutations in EYA1. 17 -20 Screening of the coding region of EYA1 in our panel of families by single-stranded conformation polymorphism (SSCP) analysis and direct sequencing detected only one alteration in five probands even though three families linked to the critical BOR region and two showed haplotype segregation consistent with linkage. However, we were able to detect deletions and complex rearrangements in the remaining four families using Southern blot analysis. Although some investigators have hypothesised that mutations in another gene in the same region could cause a BOR syndrome phenotype, 26 our data suggest that the lack of confirmed mutations in EYA1 reflects a failure to screen for complex disease-causing genomic rearrangements.
Materials and Methods
Patients and concordance studies Clinical details, pedigrees and linkage analysis of families K6015, K6030 and K6380 have been described previously. 8, 9 K6190 is a five-generation family reported to have typical but variable BOR features. Of 40 individuals, 20 affected persons have a variety of symptoms including hearing loss, branchial clefts or cysts and pre-auricular pits. Only one person has kidney failure. Some members of the family have learning problems, which may be related to the hearing loss. Peripheral blood samples were obtained from three affected individuals -the proband, her mother and her brother. The proband's father and grandfather had prelingual deafness, but no other symptoms characteristic of the BOR syndrome. Due to the lack of DNA samples on all members of K6190, concordance analysis was utilised to determine if the family should be included in the EYA1 mutation screening. A haplotype was constructed using 10 markers between D8S1060 and D8S84 to determine whether the proband, her brother and their affected mother shared a common haplotype flanking the EYA1 gene. Since the analysis did not exclude allelic association with the BOR phenotype, we included the K6190 family in the study.
K6310 is a three-generation family with five affected members sharing the phenotypic features of hearing loss, lop ear deformity, branchial fistula and kidney problems. Segregation of a presumed affected haplotype was consistent with linkage to the EYA1 region.
Cell lines and DNA samples Genomic DNA was isolated from peripheral blood by high salt precipitation. 27 Purified DNA was diluted to a concentration of 105 ng/ml. A lymphoblastoid cell line was established on the proband from K6190 using standard procedures. 4) , and exons 9 through 11 (EYA1.5), were generated by PCR amplification of the EYA1.2 clone ( Table 1) . Hybridisation of individual exons was performed using PCR products generated using the primer sets designed for SSCP analysis. 17 Intronic probes were developed using primers residing in unique sequence found with the sequences of BAC clones RP11 -11K9 (GenBank accession no. AC016465) and RP11 -326E22 (GenBank accession no. AC022858) ( Table  1) . Each intronic probe was amplified using 100 ng of genoGenomic rearrangements of EYA1 in BOR-affected patients VS Vervoort et al 758 mic DNA in a total volume of 50 ml, containing 20 mM of dNTPs, 10 mM of each primer and 0.056 mM of Taq polymerase. DNA was amplified for 35 cycles consisting of 1 min at 958C, 30 s at appropriate annealing temperature and 1 -2 min at 728C. The last extension was lengthened from 5 to 7 min. Amplification was verified by agarose electrophoresis before gel-purification with the QIAquick gel extraction kit. Intronic probes were preassociated with sonicated human placental DNA (Sigma, St Louis, MO, USA) in 50 000X excess, at 658C for 1.5 h.
Southern analysis
Five mg of each patient's genomic DNA were digested overnight at 378C using one of the following enzymes: MspI, PstI, DraI, Sau3AI, HindIII, BamHI, PvuII (New England Biolabs 1 , Inc., Beverly, MA, USA). Digested DNA was electrophoresed on a 0.8% Seakem 1 LE agarose gel (BMA, Rockland, ME, USA) and transferred by alkali blotting to a Hybon-N+ membrane (Amersham Pharmacia Biotech, Piscataway, NJ, USA) according to the manufacturer's protocol. The filters were pre-hybridised for 5 h at 658C in hybridisation solution (4X SSPE, 2X Denhardt's solution, 0.5% SDS, 6% Polyethyleneglycol, 40 mg/ml denatured sonicated salmon sperm DNA) before adding the denatured probe. After 18 h of hybridisation, filters were washed at 658C, using a final wash of 0.1X SSC, 0.1% SDS. The filters were exposed to X-ray Biomax film, using standard techniques.
Densitometry
Densitometric analysis of Southern filters hybridised with EYA1 probes was performed as previously described using the Molecular Dynamics 300A Computing Densitometer (Amersham Pharmacia Biotech, Piscataway, NJ, USA). 29 A single copy probe from chromosome 4 (D4S12) was hybridised to each filter as a control. Hybridisation signals of both D4S12 and the particular EYA1 probes were measured.
RNA extraction, cDNA synthesis and amplification Total RNA was extracted from lymphoblastoid cell lines (approximately 3610 6 cells) using TRIzol 1 LS (Life Technologies) according to the manufacturer's procedure. Samples were treated with DNase I/Amp (Life Technologies) for 15 min at room temperature and purified using the RNeasy Mini Kit (QIAGEN, Valencia, CA, USA). Approximately 3 mg of total RNA were reverse-transcribed into cDNA using random hexamers (SuperScript TM Preamplification System, Life Technologies). The cDNA templates were tested by amplification of exon 10 of the alpha subunits of IkappaB kinase (IIKa) gene, known to be ubiquitously expressed, using forward primer 5'-TCC TCG GAA ACC AGC CTC TCA ATG T-3' in exon 9 and reverse 5'-TAA AGT GTG GGC TGA AGC AGT GCA-3' in exon 11 under the following conditions: 35 cycles consisting of 1 min at 958C, 1 min at 558C, 30 s at 728C. The last extension was lengthened to 5 min.
Amplification of the full-length EYA1 cDNA To obtain full-length EYA1 cDNA, a 1/100 dilution of Human Foetal Kidney 5' stretch Plus cDNA library (Clontech, Palo Alto, CA, USA) was amplified using primers 'EYA1cDNA' ( Table 1 ). The PCR reaction was performed in a total volume of 50 ml, containing 20 mM of dNTPs, 10 mM of each primer and one unit of Sigma Taq polymerase. The cDNA was amplified for 35 cycles consisting of 1 min at 958C, 1 min at 628C, 2 min at 728C. The last extension was lengthened to 7 min. Alignment between the known EYA1 cDNA sequence (GenBank accession no.Y10260) and the kidney cDNA 
*exon 1' alternative splicing. **Touchdown PCR. ***estimated size. All intronic primers were designed in EYA1 non-coding sequences from BAC RP11-11K9 and RP11-326E22, with the exception of primers RP11-99A14, which are from BAC RP11-99A14 and lie outside of the EYA1 gene. 
Results

SSCP and sequence analysis
A small insertion/deletion in the K6030 family Seventeen primer pairs were used for the amplification of EYA1 exons using genomic DNA of unaffected and affected individuals from all families. SSCP electrophoresis detected a mobility shift in exon 9 of kindred K6030 ( Figure 1A) . After cloning the PCR product, multiple clones were sequenced to isolate both mutated and normal alleles. A T?AG change at base 107 of exon 9 created a frameshift that causes an immediate stop codon (TAG) and truncation of the EYA1 gene product ( Figure 1B ). The T?AG alteration also creates a StyI restriction site, which allowed us to amplify and digest genomic DNA of all the family members. Segregation of this mutation in the K6030 family confirmed that it was linked to the BOR phenotype (data not shown).
Other than an already characterised polymorphism (C1179T) in exon 12, 18 no differences between the other patients and controls could be detected by SSCP analysis. All EYA1 exons were amplified and bi-directionally sequenced from genomic DNA of the proband in all families. No additional sequence alterations were detected.
Southern analysis
A 70 bp deletion in the K6380 family Since all PCR-based procedures failed to detect mutations in four families linked to the BOR critical region, digested genomic DNA from the four probands and two controls was hybridised with EYA1 cDNA probes to screen for deletions, duplications and complex rearrangements. Potential deletions/duplications were analysed by densitometry. Hybridisation of a DraI Southern filter with probes EYA1.2 (exons 1 to 12) and EYA1.4 (exons 4 to 8) detected an extra fragment of about 550 bp in the proband from K6380, whereas the EYA1.1 probe (5'UTR to exon 3) did not ( Figure 2A) . Also, the normal exon 7 fragment (655 bp) was of lower intensity. Therefore, the shifted fragment was assumed to contain exon 7. Amplification of the patient's genomic DNA using exon 6 forward and exon 7 reverse primers, followed by a DraI digestion of the 831 bp product, confirmed the presence of a 550 bp extra fragment, which is absent in control DNA ( Figure 2B) . Sequencing of the 550 bp fragment revealed a 70 bp deletion starting in intron 6, 15 bp before exon 7 and extending into exon 7 ( Figure 2C) . Segregation of the deleted allele with the BOR phenotype was confirmed by amplification of exon 7 17 in seven affected and four unaffected relatives (data not shown).
A large deletion in the K6190 family Hybridisation of a PstI filter with probe EYA1.1 (5'UTR to exon 3) revealed that one copy of exons 2 and 3, but not exons 1 and 1', were probably deleted in the proband of K6190 because the fragments exhibited lower intensities ( Figure 3A ). Hybridisation of a DraI filter with probe EYA1.4 revealed that exons 4 to 8 also were deleted ( Figure 3B ). Hybridisation with probe EYA1.3 (exon 13 to 3'UTR) on a PstI filter looked normal ( Figure 3C ). Finally, hybridisation with probe EYA1.5 (exon 9 to 11) revealed that one copy of exon 9 was probably absent but that exon 11 was present ( Figure 3D ). These results were confirmed by densitometric analysis ( Table 2 ). 
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RT -PCR using primers in exons 1 and 13 ( Table 1) allowed amplification of four products of sizes smaller than expected for the normal allele in the K6190 proband only (data not shown). After gel-purification, each amplification product was directly sequenced and revealed a deletion of exons 2 through 9. The four products corresponded to different combinations of alternative splicing of exon 1' and 10. Amplification of a human foetal kidney cDNA library had previously identified a novel isoform of the EYA1 gene (Vervoort, unpublished data; GenBank accession no. AF467247) revealing alternative splicing of exon 10, which was consistent with the RT -PCR results. Therefore, the combined results from Southern hybridisation and RT -PCR strongly suggest a deletion of exons 2 to 9, and located the deletion breakpoint regions within intron 1' and intron 9. Hybridisation of a HindIII filter with probe EYA1.1 allowed detection of a shifted fragment and placed the 5'end of the deletion close to exon 1' (Figure 4A ). Hybridisation with probe intron 9C allowed us to detect the same shifted fragment as detected with exon 1', thereby identifying the 3' end of the deletion ( Figure 4B , Table 2 ). Using primers 'DeletionK6190' (Table 1 ) designed according to these results, it was possible to amplify a 2 kb PCR product from the three affected members of K6190, but not from a control ( Figure 4C ). Sequencing of the 2 kb fragment revealed it resulted from a 85 kb deletion, the 5'end breakpoint being located in intron 1', 757 bp after the end of exon 1' and the 3' end breakpoint being located in intron 9, 6.9 kb downstream of exon 9 ( Figure 4D ). All three affected members of K6190 family had the exact same breakpoint sequence. A BLAST search (http:// www.ncbi.hlm.nih.gov/blast) using sequence from the breakpoint junction fragment identified a 24 bp insertion, which was 100% homologous to a contig from the BAC clone RP11 -11K9, which contains the EYA1 gene. It was not possible to determine if the 24 bp sequence was part of intron 10 or mapped upstream of the EYA1 coding sequence. This insertion was preceded by 3 bp sequence (TAG) of unknown origin.
A large inversion in the K6015 family Both probes EYA1.2 (exons 1 to 12) and EYA1.1 (5'UTR to exon 3) revealed an extra 1.7 kb fragment in K6015 on a PstI filter ( Figure 3A ). Exons 1, 1', 2 and 3 were hybridised individually and only exon 1' hybridised to the extra fragment ( Figure 5A ). Inverse-PCR of the self-ligated PstI digested fragment, using exon 1' complementary primers (Table 1 ) allowed amplification of the unknown flanking sequence. By direct sequencing of the I-PCR product, we identified a new 565 bp sequence starting 141 bp after the end of exon 1'. A BLAST search against the 'high through genome sequence' (htgs) database from NCBI using the new sequence identified a BAC clone, RP11 -99A14 (GenBank accession no. AC022826) that mapped to chromosome 8. Using the electronic PCR option from NCBI (http:// www.ncbi.nlm.nih.gov/genome/sts/epcr.cgi), nine markers were identified, including D8S1972 and D8S1172, in this BAC. These markers allowed us to map the unknown (Table 1 ) from the flanking sequences of the breakpoints (intron 1' and telomeric sequence), it was possible to amplify and sequence a 530 bp fragment, revealing a head to tail conformation, which confirmed the inversion rearrangement ( Figure 5B ). An 8 bp sequence 'TGACTTAC' from intron 1' was found to be present at both breakpoints of the inversion in opposite directions and a 3 bp sequence (CTT) from BAC RP11 -99A14 was missing ( Figure 5B ). The breakpoint occurred within EST sts-AA025113, 159 bp upstream of a polyadenylation site. This EST corresponds to the 3'UTR of a gene of unknown function (Unigene cluster Hs.61250) composed of four overlapping ESTs. Southern hybridisation of a K6015 family PstI filter with a probe containing the sequence of the breakpoint region from BAC clone RP11 -99A14 (Table 1) identified a second shifted fragment of 2.3 kb, along with the originally observed 1.7 kb shifted fragment, corresponding to the other end of the rearrangement that was only present in the nine affected members of the K6015 family ( Figure 5C ).
A complex rearrangement in the K6310 family Hybridisation of a PstI filter with probe EYA1.1 showed exons 1, 1' and 2 had normal intensities but exon 3 had reduced intensity in the K6310 proband ( Table 2 ). Hybridisation of another PstI filter with probe EYA1.4 showed that exons 4 and 5 had a lower intensity but exons 6 through 8 were present in two copies ( Table 2 ). Hybridisation of a Sau3AI filter with probe EYA1.5 showed that exon 9 was normal, but surprisingly exon 11 was less intense ( Table 2 ). Hybridisation of a MspI filter with exon 10 and its flanking sequence showed that it also had a lower intensity ( Table  2) . Hybridisation of a PstI filter with probe EYA1.3 showed that exons 13 though 15 were less intense but exon 16 was normal (Table 2) . And finally exon 15 and its flanking sequences were hybridised to a PstI filter and also exhibited a reduction in intensity (Table 2) .
Based on these results, exons 3 through 5 and exons 10 through 15 appear to be deleted, whereas exons 1 -2, 6 through 9 and exon 16 seem normal. Hybridisation with probes from introns 2, 5, 9 and 15 was performed in order to refine the four breakpoint regions (Table 3) . A polymorphism was detected in intron 15, using probe intron 15B, also revealing the presence of both copies in all the affected members of the family (data not shown). Probes from intron 5 failed either to amplify or hybridize specifically, possibly due to the high content of repeat sequences. Since none of the other probes detected any shift, long-range PCR was performed to try to amplify the breakpoints: a possible large deletion with an insertion of exons 6 through 9 outside the coding region; a potential existence of two independent deletions between introns 2 and 5 and between introns 9 and 15; a possible inversion associated with a deletion. Unfortunately, no PCR product was generated in any of these reactions. Thus, although there was good evidence that the EYA1 gene was disrupted in family K6310, it was not possible to fully characterise this complex rearrangement.
Discussion
Several mutation reports have confirmed that alterations in the human homologue of the Drosophila eyes absent gene, EYA1, cause BO/BOR syndrome. 17 -23 However, in some of these reports only 20% of the patients studied had HindIII filter hybridised with probe EYA1.5 showing lower intensity of exon 9 (3.9 kb band). Exon 11 (4 kb band) is normal. An autosomal single copy probe D4S12 is displayed for each filter.
Genomic rearrangements of EYA1 in BOR-affected patients VS Vervoort et al 762 confirmed mutations in the EYA1 gene. To explain a low mutation detection rate, some investigators have hypothesised that mutations in another gene tightly linked to EYA1 also cause BOR syndrome. 26 However, using Southern analysis it was possible to detect mutations in our panel of four families linked to chromosome 8 in which SSCP analysis and direct sequencing had failed to detect a point mutation. This underscores the major drawback of many PCR-based mutation detection procedures in the study of an autosomal dominant disorder which is the inevitable Numbers correspond to the ration between D4S12 and EYA1 signal intensities. Each time the proband's ratio was about half the control's ratio value, the exon was considered deleted. Exon status is indicated by a + (presence) or 7 (deleted) sign. ND, not determined. Genomic rearrangements of EYA1 in BOR-affected patients VS Vervoort et al 763 amplification of the normal allele, which can mask deleted or disrupted exons. 30, 31 A deletion of 85 kb was identified in family K6190, which has a typical BOR phenotype. This deletion appears to be the largest intragenic deletion thus far reported for BO/BOR syndrome. Unlike most of the reported deletions in which the translated protein would be truncated for the eyaHR domain, 17 -22 this deletion eliminates half of the exons in the variable region of EYA1 leaving most of the eyaHR domain intact. The truncated EYA1 mRNA is apparently quite stable since it was possible to amplify four truncated cDNA isoforms from this patient's lymphoblasts. This finding shows that mutations outside the highly conserved domain eyaHR can give rise to the BOR phenotype. The large paracentric inversion characterised in family K6015 is the first reported inversion that disrupts the entire EYA1 gene. One of the breakpoints is located at the 5' end Genomic rearrangements of EYA1 in BOR-affected patients VS Vervoort et al 764 of intron 1' and the other breakpoint is located outside of the EYA1 gene. This mutation indicates that if Southern analysis is used to detect rearrangements, multiple cDNA or genomic probes should be utilised since in this case most of the gene (16 exons out of 17) appeared normal by Southern analysis. Indeed, the presumed rearrangement in another family, K6310, could not be completely characterised, indicating that even Southern analysis is not capable of resolving all complex rearrangements. Although no shifted fragment could be detected, dosage analysis revealed that exons 3 to 5 and exons 10 to 15 were deleted, while exons 6 to 9 appeared normal.
Some initial reports on BOR syndrome describing one patient with a dir ins(8)(q24.11;q13.3;q21. 13) 15,32 and another patient with 8q12.2-q21 deletion 11 indicated that complex genomic rearrangements can cause a BOR phenotype. In fact, in the first two mutation reports, three large deletions of 7, 5.6 and 20 -37 kb are described. 17, 18 Including the rearrangements reported here, eight complex rearrangements, corresponding to about 21% (8/38) of published BOR mutations, have been identified. This frequency of complex rearrangements may indicate that the EYA1 region is unstable. The only mutation identified by SSCP and sequencing was a small insertion/deletion in exon 9 (T917AG) in K6030. It is interesting to note that K6030 is the second case report of a BO family with a frameshift mutation in exon 9. 23 Several clinical reports have previously suggested that the BO syndrome was allelic to the BOR syndrome, since silent renal anomalies, 33 underdiagnosed kidney problems 34 and severe renal manifestations are only expected in 6% of BOR patients. 4 K6030 is now the sixth BO family associated with EYA1 mutations. 22, 23 In conclusion, using PCR-based methods, such as SSCP and sequencing, only one point mutation in EYA1 was detected in 5 BOR families linked to chromosome 8q13.3. However, using Southern blot analysis, complex gene alterations including a large inversion and two deletions were found in the other four families. A high proportion (21%) of complex genomic rearrangements involving the EYA1 gene have been reported. However, these rearrangements can not be detected by commonly used mutation screening procedures and these data suggest that more complex rearrangements remain to be detected in BOR patients with missing mutation in EYA1. Although most mutations result in truncated proteins, the etiology is quite different for each patient, from a single base change to complex genomic rearrangements that make it impossible to use a single approach for mutation screening of EYA1. The use of Southern analysis or quantitative PCR in combination with SSCP should cover a wide range of mutations found in the EYA1 gene. Numbers correspond to the ratio between D4S12 and EYA1 signal intensities. Each time the proband's ratio was about half the control's ratio value, the exon was considered deleted. Exon status is indicated by a + (presence) or 7 (deleted) sign.
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